Windlas Biotech Limited Cash Flow Quality Index
Windlas Biotech Limited cash flow quality index. Windlas Biotech Limited (WINDLAS) has a Cash Flow Quality Index of 0.45x as of December 2023. Operating cash flow of Rs67.78 Million is below net income of Rs150.98 Million, suggesting accrual-heavy earnings not yet converted to cash. See WINDLAS FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Windlas Biotech Limited (2018–2025)
Cash flow quality index of Windlas Biotech Limited from 2018 to 2025. Historical Cash Flow Quality Index for Windlas Biotech Limited across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore cash flow to debt ratio of Windlas Biotech Limited to assess how comfortably operating cash covers total debt obligations.
Windlas Biotech Limited Cash Flow Quality Index by Year (2018–2025)
Windlas Biotech Limited cash flow quality index by year from 2018 to 2025. Year-by-year earnings quality comparison for Windlas Biotech Limited. For the full cash flow conversion analysis, see cash flow conversion of Windlas Biotech Limited.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.12x | Rs681.87 Million | Rs609.94 Million | ▼ -40.3% |
| 2024 | 1.87x | Rs1.09 Billion | Rs581.87 Million | ▲ +75.2% |
| 2023 | 1.07x | Rs609.65 Million | Rs570.39 Million | ▲ +433.4% |
| 2022 | 0.20x | Rs91.30 Million | Rs455.65 Million | ▼ -62.0% |
| 2021 | 0.53x | Rs114.54 Million | Rs217.40 Million | ▼ -48.0% |
| 2020 | 1.01x | Rs250.06 Million | Rs246.68 Million | ▲ +313.6% |
| 2019 | 0.25x | Rs186.54 Million | Rs761.15 Million | ▼ -90.7% |
| 2018 | 2.64x | Rs295.91 Million | Rs111.98 Million | — |